41 min listen
Transforming the treatment of cancer with oncolytic viruses
Transforming the treatment of cancer with oncolytic viruses
ratings:
Length:
33 minutes
Released:
Dec 2, 2020
Format:
Podcast episode
Description
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, speaks with Stephen Russell, CEO of Vyriad. Dr. Russell reveals invaluable insights for those looking for or currently putting together partnership deals. Stephen shares his journey from academia at the Mayo Clinic to founding Vyriad, and eventually partnering with Regeneron for the development of new oncolytic virus treatments for cancer. Learn how Vyriad pivoted their technology to develop antibody tests for COVID-19 during the crisis. Hosted on Acast. See acast.com/privacy for more information.
Released:
Dec 2, 2020
Format:
Podcast episode
Titles in the series (48)
To know COVID-19 is to know medicine by Conversations in Healthcare